Logotyp: till Uppsala universitets webbplats

uu.sePublikationer från Uppsala universitet
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Klinisk och experimentell patologi. Department of Pathology, Uppsala University Hospital, Uppsala, Sweden. (Irina Alafuzoff)
Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Klinisk och experimentell patologi. Department of Pathology, Uppsala University Hospital, Uppsala, Sweden. (Irina Alafuzoff)
2019 (Engelska)Ingår i: Histochemistry and Cell Biology, ISSN 0948-6143, E-ISSN 1432-119X, Vol. 151, nr 1, s. 91-96Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Immunohistochemistry (IHC) is influenced by several factors such as cold ischemia time, fixative, fixation time, paraffin, storage time, antibody, antigen retrieval technique and detection systems. In the setting of post-mortem tissue, not only post-mortem delay, but also agonal state is of interest. Here, we assessed an additional variable, i.e., the thickness of the section, and noted that this variable also influenced the IHC outcome. This is of significance when the extent of labelling is a parameter to be assessed, for example when assigning a stage or grade of a disease. Furthermore, when assessing brain tissue with neurons, soma measuring from 4 to 100 µm, various cellular compartments composed of different proteins are localised in sections measuring 4 or 7 µm. Thus, what is seen in a 7-µm-thick section might be lacking in a 4-µm-thick section. Lack of information regarding the molecular size of commercial antibodies is also disturbing as this parameter might influence the distribution of the molecule in the three-dimensional section. The choice of antibody to be used and the staining methodology have been acknowledged being of significance for IHC outcome; however, neither sections thickness or the molecular weight has been discussed sufficiently. IHC has been shown to be an unpredictable technique used for assessment of tissue. This emphasises the need for detailed methodological descriptions in publications, the need to acknowledge and to harmonize all eventual pitfalls related to this methodology.

Ort, förlag, år, upplaga, sidor
2019. Vol. 151, nr 1, s. 91-96
Nyckelord [en]
Extent of staining, Immunohistochemistry, Pitfalls, Thickness of a section
Nationell ämneskategori
Klinisk laboratoriemedicin
Forskningsämne
Patologi
Identifikatorer
URN: urn:nbn:se:uu:diva-372540DOI: 10.1007/s00418-018-1742-1ISI: 000455442800009PubMedID: 30357509OAI: oai:DiVA.org:uu-372540DiVA, id: diva2:1276043
Forskningsfinansiär
Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse för medicinsk forskningTillgänglig från: 2019-01-07 Skapad: 2019-01-07 Senast uppdaterad: 2021-02-03Bibliografiskt granskad
Ingår i avhandling
1. Alzheimer's Disease Neuropathological Change and neuronal and glial alterations in patients with idiopathic Normal Pressure Hydrocephalus
Öppna denna publikation i ny flik eller fönster >>Alzheimer's Disease Neuropathological Change and neuronal and glial alterations in patients with idiopathic Normal Pressure Hydrocephalus
2021 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Alzheimer’s disease Neuropathological Change (ADNC), i.e. amyloid β (Aβ) and hyperphosphorylated τ (HPτ), is seen in excess in the brains of subjects with AD. Idiopathic Normal Pressure Hydrocephalus (iNPH) lacks defined hallmark lesions, affects the elderly and leads to cognitive impairment, gait disturbance and urinary incontinence that can be treated with a ventriculoperitoneal shunt (VPS). A few centres around the world have obtained a brain biopsy from the area of VPS. It has been reported that the presence of ADNC in the biopsy is associated with progression to AD.

We confirm that majority of iNPH subjects display ADNC, and the ADNC increases in extent with age, in line with AD. The HPτ pathology is sparse in majority of cases. We observed remarkable neuronal survival and loss of matrix/synapses in subjects with iNPH (paper III).

When studying subjects with notable Aβ pathology (paper IV), we observed a stepwise increase of pyroglutamylated Aβ (pyAβ) and phosphorylated Aβ variants in iNPH. These two Aβ variants are associated with symptomatic AD and correlate with HPτ pathology. The pyAβ in the frontal cortex is a predictive marker for AD. Thus, notable Aβ pathology in presence of HPτ in iNPH is suggestive of a moderate level of ADNC.  

When assessing changes in the extent of pathology occurring during 21 months in a frontal cortex of a subject with iNPH and AD (paper II), HPτ pathology increased in parallel with neuronal and synaptic loss, whereas Aβ pathology and astroglial activity were stable over time. In contrast, we observed reduction of microglial markers, which might explain why anti-inflammatory treatment is effective only at an early stage of AD.

When assessing brain tissue, the section thickness must be standardised, as it affects the staining outcome and diagnosis (paper I).

In conclusion, we have demonstrated a progressive neurodegeneration of ADNC type in a population of iNPH subjects, mimicking what is seen in subjects with AD. A brain biopsy obtained from subjects with iNPH should be obligatory. This is because when ADNC is present in the biopsy, representing prodromal AD, contact with memory clinic should be initiated.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2021. s. 76
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 1719
Nyckelord
idiopathic Normal Pressure Hydrocephalus, Alzheimer’s disease, amyloid β, hyperphosphorylated τ
Nationell ämneskategori
Annan klinisk medicin
Forskningsämne
Patologi
Identifikatorer
urn:nbn:se:uu:diva-433963 (URN)978-91-513-1132-6 (ISBN)
Disputation
2021-03-27, Rudbecksalen, Rudbeckslaboratoriet, Dag Hammarskjölds väg 20, Uppsala, 09:15 (Engelska)
Opponent
Handledare
Tillgänglig från: 2021-03-05 Skapad: 2021-02-03 Senast uppdaterad: 2021-03-29

Open Access i DiVA

fulltext(1314 kB)506 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1314 kBChecksumma SHA-512
60e45eec7fb001255d626ab4462fbfab700193b74d6e30237b97d15a47881cd8961c4fe1eef10b523af97baace8b95448742f907ba827df3bc28513981fcf5a6
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Person

Libard, SylwiaCerjan, DijanaAlafuzoff, Irina

Sök vidare i DiVA

Av författaren/redaktören
Libard, SylwiaCerjan, DijanaAlafuzoff, Irina
Av organisationen
Klinisk och experimentell patologi
I samma tidskrift
Histochemistry and Cell Biology
Klinisk laboratoriemedicin

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 506 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 517 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf